ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2023 Insights: "RedirecTT-1 Study Summary - Teclistamab + Talquetamab Targeting BCMA and GPRC5D in Patients With R/R MM"
By
ecancer
FEATURING
Yael C. Cohen
By
ecancer
FEATURING
Yael C. Cohen
Login to view comments.
Click here to Login
